Cargando…

Challenges with scale-up of GeneXpert MTB/RIF® in Uganda: a health systems perspective

BACKGROUND: Many high burden countries are scaling-up GeneXpert® MTB/RIF (Xpert) testing for tuberculosis (TB) using a hub-and-spoke model. However, the effect of scale up on reducing TB has been limited. We sought to characterize variation in implementation of referral-based Xpert TB testing across...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nalugwa, Talemwa, Shete, Priya B., Nantale, Mariam, Farr, Katherine, Ojok, Christopher, Ochom, Emma, Mugabe, Frank, Joloba, Moses, Dowdy, David W., Moore, David A. J., Davis, J. Lucian, Cattamanchi, Adithya, Katamba, Achilles
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057496/ https://www.ncbi.nlm.nih.gov/pubmed/32131814 http://dx.doi.org/10.1186/s12913-020-4997-x

Ejemplares similares

Quality of care for patients evaluated for tuberculosis in the context of Xpert MTB/RIF scale-up
por: Farr, Katherine, et al.
Publicado: (2019)

Implementation of Xpert MTB/RIF in Uganda: Missed Opportunities to Improve Diagnosis of Tuberculosis
por: Hanrahan, Colleen F., et al.
Publicado: (2016)

Population-Level Impact of Same-Day Microscopy and Xpert MTB/RIF for Tuberculosis Diagnosis in Africa
por: Dowdy, David W., et al.
Publicado: (2013)

Readiness to implement on-site molecular testing for tuberculosis in community health centers in Uganda
por: Nalugwa, Talemwa, et al.
Publicado: (2022)

Sputum quality and diagnostic performance of GeneXpert MTB/RIF among smear-negative adults with presumed tuberculosis in Uganda
por: Meyer, Amanda J., et al.
Publicado: (2017)

Study protocol: a cluster randomized trial to evaluate the effectiveness and implementation of onsite GeneXpert testing at community health centers in Uganda (XPEL-TB)
por: Reza, Tania F., et al.
Publicado: (2020)

Feasibility of a short message service (SMS) intervention to deliver tuberculosis testing results in peri-urban and rural Uganda
por: Babirye, Diana, et al.
Publicado: (2019)

Empiric treatment of pulmonary TB in the Xpert era: Correspondence of sputum culture, Xpert MTB/RIF, and clinical diagnoses
por: Kendall, Emily A., et al.
Publicado: (2019)

Evaluation of GeneXpert MTB/RIF for Diagnosis of Tuberculous Meningitis
por: Nhu, Nguyen Thi Quynh, et al.
Publicado: (2014)

Where will it end? Pathways to care and catastrophic costs following negative TB evaluation in Uganda
por: Samuels, Thomas H. A., et al.
Publicado: (2021)

Feasibility of a multifaceted intervention to improve treatment initiation among patients diagnosed with TB using Xpert MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2022)

Patient and health system factors associated with pretreatment loss to follow up among patients diagnosed with tuberculosis using Xpert® MTB/RIF testing in Uganda
por: Zawedde-Muyanja, Stella, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy
por: Shete, P. B., et al.
Publicado: (2017)

Evaluation of the GeneXpert MTB/RIF in patients with presumptive tuberculous meningitis
por: Metcalf, Tatiana, et al.
Publicado: (2018)

The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa
por: Meyer-Rath, Gesine, et al.
Publicado: (2012)

Role of GeneXpert MTB/Rif Assay in Diagnosing Tuberculosis in Pregnancy and Puerperium
por: Habib, Zaiyad G., et al.
Publicado: (2015)

Evaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
por: Moussa, Husseiny Sh., et al.
Publicado: (2016)

Evaluation of GeneXpert MTB/RIF system performances in the diagnosis of extrapulmonary tuberculosis
por: Mechal, Youness, et al.
Publicado: (2019)

Feasibility and Sensitivity of Saliva GeneXpert MTB/RIF Ultra for Tuberculosis Diagnosis in Adults in Uganda
por: Byanyima, Patrick, et al.
Publicado: (2022)

Diagnostic performance of GeneXpert MTB/RIF in detecting MTB in smear-negative presumptive TB patients
por: Rimal, Raksha, et al.
Publicado: (2022)

Evaluation of GeneXpert MTB/RIF for detecting Mycobacterium tuberculosis in a hospital in China
por: Tang, Tingyu, et al.
Publicado: (2017)

GeneXpert MTB/RIF assay in the diagnosis of urinary tuberculosis from urine specimens
por: Pang, Yu, et al.
Publicado: (2017)

GeneXpert(®) MTB/RIF assay with transbronchial lung cryobiopsy for Mycobacterium tuberculosis diagnosis
por: Sánchez-Cabral, Olivia, et al.
Publicado: (2020)

Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion
por: Jain, Jyoti, et al.
Publicado: (2021)

Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out
por: Muttamba, Winters, et al.
Publicado: (2018)

Assessment of GeneXpert MTB/RIF Performance by Type and Level of Health-Care Facilities in Nigeria
por: Gidado, Mustapha, et al.
Publicado: (2019)

Evaluation of the use of GeneXpert MTB/RIF in a zone with high burden of tuberculosis in Thailand
por: Pongpeeradech, Nathakorn, et al.
Publicado: (2022)

The Value of GeneXpert MTB/RIF for Detection in Tuberculosis: A Bibliometrics-Based Analysis and Review
por: Li, Zhiyi
Publicado: (2022)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Multicomponent strategy with decentralised molecular testing for tuberculosis in Uganda: a cost and cost-effectiveness analysis
por: Thompson, Ryan R, et al.
Publicado: (2023)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

Impact of Xpert MTB/RIF Testing on Tuberculosis Management and Outcomes in Hospitalized Patients in Uganda
por: Yoon, Christina, et al.
Publicado: (2012)

Impact of GeneXpert MTB/RIF® on treatment initiation and outcomes of RIF-resistant and RIF-susceptible TB patients in Vladimir TB dispensary, Russia
por: Ershova, Julia V., et al.
Publicado: (2020)

Detection of Mycobacterium tuberculosis in AFB smear-negative sputum specimens through MTB culture and GeneXpert(®) MTB/RIF assay
por: Rasool, Ghulam, et al.
Publicado: (2019)

GeneXpert MTB/RIF Outperforms Mycobacterial Culture in Detecting Mycobacterium tuberculosis from Salivary Sputum
por: Shi, Jin, et al.
Publicado: (2018)

Evaluation of stool GeneXpert MTB/RIF for the diagnosis of pulmonary tuberculosis among presumptive patients in Tanzania
por: Ngadaya, Esther, et al.
Publicado: (2020)

Role of GeneXpert MTB/RIF assay for the diagnosis of cervical lymph node tuberculosis and rifampicin resistance
por: Mukhida, Sahjid, et al.
Publicado: (2022)

GeneXpert MTB/RIF Ultra performance to detect uncommon rpoB mutations in Mycobacterium tuberculosis
por: Rigouts, Leen, et al.
Publicado: (2023)

Discordance of the Repeat GeneXpert MTB/RIF Test for Rifampicin Resistance Detection Among Patients Initiating MDR-TB Treatment in Uganda
por: Ssengooba, Willy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bml4v6i0bd5kg6o86k4kgf6k2h